AssetMark Inc
AGN

AssetMark Inc’s Allergan plc AGN Stock Holding History

AssetMark Inc’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-30,313
Closed -$5.37M – 1507
2020
Q1 		$5.37M Buy
30,313
+30,040
+11,004% +$5.66M 0.05% 210
2019
Q4 		$52K Sell
273
-41
-13% -$7.4K ﹤0.01% 742
2019
Q3 		$53K Sell
314
-65
-17% -$10.6K ﹤0.01% 704
2019
Q2 		$63K Sell
379
-134
-26% -$18.6K ﹤0.01% 665
2019
Q1 		$75K Sell
513
-89
-15% -$12.9K ﹤0.01% 629
2018
Q4 		$80K Sell
602
-459
-43% -$75.2K ﹤0.01% 602
2018
Q3 		$202K Sell
1,061
-181
-15% -$33.3K ﹤0.01% 455
2018
Q2 		$207K Sell
1,242
-202
-14% -$32.4K ﹤0.01% 451
2018
Q1 		$243K Sell
1,444
-957
-40% -$161K ﹤0.01% 421
2017
Q4 		$393K Sell
2,401
-107
-4% -$19.2K ﹤0.01% 394
2017
Q3 		$514K Buy
2,508
+29
+1% +$6.74K 0.01% 353
2017
Q2 		$603K Sell
2,479
-78
-3% -$18.3K 0.01% 328
2017
Q1 		$611K Sell
2,557
-7,240
-74% -$1.69M 0.01% 316
2016
Q4 		$2.06M Buy
9,797
+6,933
+242% +$1.44M 0.03% 220
2016
Q3 		$660K Buy
2,864
+18
+0.6% +$4.4K 0.01% 288
2016
Q2 		$658K Sell
2,846
-1,201
-30% -$277K 0.01% 295
2016
Q1 		$1.08M Sell
4,047
-64
-2% -$18.3K 0.02% 259
2015
Q4 		$1.28M Buy
4,111
+3,868
+1,592% +$1.15M 0.02% 251
2015
Q3 		$66K Sell
243
-2,690
-92% -$826K ﹤0.01% 377
2015
Q2 		$890K Buy
2,933
+1,350
+85% +$403K 0.02% 305
2015
Q1 		$471K Buy
+1,583
New +$451K 0.01% 351

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

AssetMark Inc's AGN Position: Q2 2020 in Review

AssetMark Inc sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 30,313 shares — an estimated $5.37M sold.

AssetMark Inc first reported a position in AGN in Q1 2015 and held it in 21 quarters. The position peaked at $5.37M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • AssetMark Inc reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • AssetMark Inc sold 30,313 Allergan plc shares in Q2 2020, an estimated $5.37M.
  • AssetMark Inc first reported a position in Allergan plc in Q1 2015 and held it in 21 quarters.
  • AssetMark Inc's Allergan plc position peaked at $5.37M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on AssetMark Inc's 13F filing for Q2 2020, filed 11 Aug 2020.